In vivo tumor xenograft model

TS Takashi Sakaguchi
HY Hirofumi Yoshino
SS Satoshi Sugita
KM Kazutaka Miyamoto
MY Masaya Yonemori
YO Yoichi Osako
MM Makiko Meguro-Horike
SH Shin-Ichi Horike
MN Masayuki Nakagawa
HE Hideki Enokida
request Request a Protocol
ask Ask a question
Favorite

A mixture containing 100 µL SU-R-786-o cells (5 × 106 cells) or 786-o cells (3 × 106 cells) and 100 µL Matrigel Matrix (Corning, Bedford, MA, USA) was injected subcutaneously into the flanks of female nude mice (BALB/c nu/nu, 6- to 8-weeks-old). (+)-JQ1 (HY-13030; MCE, NJ, USA) was prepared in a vehicle of 10% dimethylsulfoxide and 10% hydroxypropyl-β-cyclodextrin (Sigma, St. Louis, MO, USA) solution and injected at 50 mg/kg intraperitoneally once daily, beginning the day after tumor cell inoculation. The dose was adjusted according to the weight of each mouse, and the volume of injection did not exceed 150 μL. All animal experiments were approved by the animal care review board of Kagoshima University.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A